Evolving Strategies for Leveraging SGLT2 Inhibitor Therapy in Type 2 Diabetes

Get patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

This activity is supported by an independent educational grant from

Boehringer Ingelheim